Literature DB >> 10982817

A deubiquitinating enzyme UBPY interacts with the Src homology 3 domain of Hrs-binding protein via a novel binding motif PX(V/I)(D/N)RXXKP.

M Kato1, K Miyazawa, N Kitamura.   

Abstract

Hrs-binding protein (Hbp) is a Src homology 3 (SH3) domain-containing protein that tightly associates with Hrs. Hbp together with Hrs is thought to play a regulatory role in endocytic trafficking of growth factor-receptor complexes through early endosomes. Association of Hbp with a binding partner(s) via the SH3 domain seems to be essential for Hbp to exert its function. In this study, we searched for Hbp-binding proteins by a far Western screening and isolated a mouse cDNA clone encoding a deubiquitinating enzyme mUBPY as an Hbp SH3-binding protein. mUBPY has two Hbp-SH3 domain binding sites. Mutagenic analysis identified a consensus sequence PX(V/I)(D/N)RXXKP as the Hbp-SH3 domain binding motif. It is a novel SH3-binding motif and does not contain the canonical proline-rich consensus binding motif, PXXP. Ubiquitination of growth factor receptors is thought to regulate their intracellular degradation. Thus, UBPY may play a regulatory role in the degradation by interaction with the SH3 domain of Hbp via the novel SH3-binding motif.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982817     DOI: 10.1074/jbc.M007251200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Bilayered clathrin coats on endosomal vacuoles are involved in protein sorting toward lysosomes.

Authors:  Martin Sachse; Sylvie Urbé; Viola Oorschot; Ger J Strous; Judith Klumperman
Journal:  Mol Biol Cell       Date:  2002-04       Impact factor: 4.138

2.  Identification of molecular vulnerabilities in human multiple myeloma cells by RNA interference lethality screening of the druggable genome.

Authors:  Rodger E Tiedemann; Yuan Xao Zhu; Jessica Schmidt; Chang Xin Shi; Chris Sereduk; Hongwei Yin; Spyro Mousses; A Keith Stewart
Journal:  Cancer Res       Date:  2011-12-06       Impact factor: 12.701

3.  The FAM deubiquitylating enzyme localizes to multiple points of protein trafficking in epithelia, where it associates with E-cadherin and beta-catenin.

Authors:  Rachael Z Murray; Lachlan A Jolly; Stephen A Wood
Journal:  Mol Biol Cell       Date:  2004-01-23       Impact factor: 4.138

4.  Acrosome biogenesis: Revisiting old questions to yield new insights.

Authors:  Giovanna Berruti; Chiara Paiardi
Journal:  Spermatogenesis       Date:  2011-04

5.  Novel roles for the E3 ubiquitin ligase atrophin-interacting protein 4 and signal transduction adaptor molecule 1 in G protein-coupled receptor signaling.

Authors:  Rohit Malik; Unice J K Soh; JoAnn Trejo; Adriano Marchese
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

Review 6.  The ESCRT complexes.

Authors:  James H Hurley
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-07-23       Impact factor: 8.250

7.  The deubiquitinating enzyme Ubp1 affects sorting of the ATP-binding cassette-transporter Ste6 in the endocytic pathway.

Authors:  Carolin Schmitz; Andrea Kinner; Ralf Kölling
Journal:  Mol Biol Cell       Date:  2005-01-05       Impact factor: 4.138

8.  Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and Pex13p.

Authors:  Keiichiro Kami; Ryu Takeya; Hideki Sumimoto; Daisuke Kohda
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

9.  STAM proteins bind ubiquitinated proteins on the early endosome via the VHS domain and ubiquitin-interacting motif.

Authors:  Emi Mizuno; Kensuke Kawahata; Masaki Kato; Naomi Kitamura; Masayuki Komada
Journal:  Mol Biol Cell       Date:  2003-06-13       Impact factor: 4.138

10.  Hse1, a component of the yeast Hrs-STAM ubiquitin-sorting complex, associates with ubiquitin peptidases and a ligase to control sorting efficiency into multivesicular bodies.

Authors:  Jihui Ren; Younghoon Kee; Jon M Huibregtse; Robert C Piper
Journal:  Mol Biol Cell       Date:  2006-11-01       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.